EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study

Asma M. Alshahrani, Sarah M. Alyousif, Geetha Kandasamy, Sitah Alharthi, Sami Alsalmi, Abdullah Sameer Alshammari, Ada Al-Qunaibet

Life · 13.11.2026 · 16 (11) · 1921

DOI: 10.3390/life16111921 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Life, online erschienen am 13.11.2026. Verfasst von Asma M. Alshahrani und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) is associated with substantial morbidity and frequently occurs alongside multiple comorbidities, contributing to complex medication use. This study aimed to describe the clinical characteristics, comorbidities, laboratory findings, and medication use among patients with HF in Saudi Arabia, focusing on sex differences.

Methods

A retrospective cross-sectional study was conducted among adults with heart failure at King Abdul-Aziz Medical City, Saudi Arabia. Data from electronic medical records (2016–2018) were analyzed for demographic, clinical, laboratory, comorbidity, and medication characteristics. Differences between male and female patients were assessed using appropriate statistical tests, with odds ratios and 95% confidence intervals calculated for selected variables. Statistical significance was set at p < 0.05.

Results

Among 1363 patients, 669 (49.1%) were male and 694 (50.9%) female. Females had higher BMI (34.64 ± 7.99 vs. 28.99 ± 6.91 kg/m2, p < 0.001), hypertension (50.7% vs. 41.4%; p < 0.001), diabetes (47.4% vs. 40.7%; p = 0.012), and atrial fibrillation (29.7% vs. 20.0%; p < 0.001). Males had higher smoking prevalence (60.4% vs. 3.3%; p < 0.001), ischaemic heart disease (43.6% vs. 27.1%; OR 2.08, 95% CI 1.66–2.61; p < 0.001), creatinine (p < 0.001), and BNP (p = 0.004). Beta-blocker and ACE inhibitor use was higher among males, whereas ARB use was higher among females (all p < 0.05).

Conclusions

In this study, patients with heart failure had a high burden of cardiovascular and cardiometabolic comorbidities, with notable sex-related differences in clinical characteristics, comorbidities, laboratory measures, and medication use. These findings provide real-world evidence on HF profiles and medication use in a Saudi tertiary-care setting and highlight the need for multicenter studies to characterize these patterns across diverse populations.

Förderung

  • King Khalid University

Zitieren

APA

Alshahrani, A. M., Alyousif, S. M., Kandasamy, G., Alharthi, S., Alsalmi, S., Alshammari, A. S., & Al-Qunaibet, A. (2026). Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study. Life, 16(11), 1921. https://doi.org/10.3390/life16111921

Vancouver

Alshahrani AM, Alyousif SM, Kandasamy G, Alharthi S, Alsalmi S, Alshammari AS, et al. Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study. Life. 2026;16(11):1921. doi:10.3390/life16111921

BibTeX
@article{Alshahrani2026,
  author = {Alshahrani, Asma M. and Alyousif, Sarah M. and Kandasamy, Geetha and Alharthi, Sitah and Alsalmi, Sami and Alshammari, Abdullah Sameer and Al-Qunaibet, Ada},
  title = {Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1921},
  doi = {10.3390/life16111921}
}
Kostenlos starten →